1
Clinical Trials associated with COVID-2019 DNA vaccine (Immuno Cure 3)A Phase 1, Randomized, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19 in Healthy Adults
To investigate the safety and immunogenicity profile of of a novel and investigational SARS-CoV-2 DNA vaccine, which is delivered intramuscularly followed by electroporation to enhance vaccine penetration, as a potential prophylactic vaccine for current pandemic disease COVID-19.
100 Clinical Results associated with COVID-2019 DNA vaccine (Immuno Cure 3)
100 Translational Medicine associated with COVID-2019 DNA vaccine (Immuno Cure 3)
100 Patents (Medical) associated with COVID-2019 DNA vaccine (Immuno Cure 3)
100 Deals associated with COVID-2019 DNA vaccine (Immuno Cure 3)